{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:55:29Z","timestamp":1790848529794,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["24ZXGZSY00130"],"award-info":[{"award-number":["24ZXGZSY00130"]}],"id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2024ZD031"],"award-info":[{"award-number":["2024ZD031"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470527"],"award-info":[{"award-number":["82470527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.amjmed.2026.03.049","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:19:28Z","timestamp":1775603968000},"page":"1518-1526.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of spironolactone in patients with heart failure with preserved ejection fraction following acute myocardial infarction: A multicenter retrospective cohort analysis"],"prefix":"10.1016","volume":"139","author":[{"given":"Lei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Shu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-6438","authenticated-orcid":false,"given":"Kang-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjmed.2026.03.049_bib0001","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.amjmed.2026.03.049_bib0002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the global registry of acute coronary events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2026.03.049_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002460","article-title":"Mortality associated with heart failure after myocardial infarction: a contemporary community perspective","volume":"9","author":"Gerber","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.amjmed.2026.03.049_bib0004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/clc.20922","article-title":"Heart failure after myocardial infarction: clinical implications and treatment","volume":"34","author":"Minicucci","year":"2011","journal-title":"Clin Cardiol"},{"issue":"27","key":"10.1016\/j.amjmed.2026.03.049_bib0005","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.amjmed.2026.03.049_bib0006","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/CIRCULATIONAHA.108.784215","article-title":"Long-term trends in the incidence of heart failure after myocardial infarction","volume":"118","author":"Velagaleti","year":"2008","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.amjmed.2026.03.049_bib0007","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2026.03.049_bib0008","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.amjmed.2026.03.049_bib0009","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"127","author":"Pt","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2026.03.049_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ehf2.13070","article-title":"Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction","volume":"8","author":"Kamon","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.amjmed.2026.03.049_bib0011","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.amjcard.2006.12.057","article-title":"Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes","volume":"99","author":"Bennett","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2026.03.049_bib0012","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1016\/j.amjmed.2026.03.049_bib0013","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.amjmed.2026.03.049_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032231","article-title":"Spironolactone reduces the risk of death in veterans with heart failure with preserved ejection fraction","volume":"13","author":"Kurgansky","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.amjmed.2026.03.049_bib0015","article-title":"Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction","volume":"5","author":"Martin","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.amjmed.2026.03.049_bib0016","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.amjmed.2026.03.049_bib0017","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2026.03.049_bib0018","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"16","key":"10.1016\/j.amjmed.2026.03.049_bib0019","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2026.03.049_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pst.537","article-title":"Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study","volume":"11","author":"Gayat","year":"2012","journal-title":"Pharm Stat"},{"issue":"26","key":"10.1016\/j.amjmed.2026.03.049_bib0021","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2026.03.049_bib0022","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.healun.2021.02.019","article-title":"Long-term adult congenital heart disease survival after heart transplantation: a restricted mean survival time analysis","volume":"40","author":"Dolgner","year":"2021","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.amjmed.2026.03.049_bib0023","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2026.03.049_bib0024","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.amjmed.2026.03.049_bib0025","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.3390\/jcm14103598","article-title":"Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"14","author":"Zaheen","year":"2025","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.amjmed.2026.03.049_bib0026","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jchf.2023.07.014","article-title":"Pharmacological treatments in heart failure with mildly reduced and preserved ejection fraction: systematic review and network meta-analysis","volume":"12","author":"Zafeiropoulos","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.amjmed.2026.03.049_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.124.072011","article-title":"Efficacy and safety of finerenone across the ejection fraction spectrum in heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the FINEARTS-HF trial","volume":"151","author":"Docherty","year":"2025","journal-title":"Circulation"},{"issue":"10458","key":"10.1016\/j.amjmed.2026.03.049_bib0028","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjmed.2026.03.049_bib0029","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.amjmed.2026.03.049_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.amjmed.2026.03.049_bib0031","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"10.1016\/j.amjmed.2026.03.049_bib0032","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.amjmed.2026.03.049_bib0033","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600272X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600272X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:13:23Z","timestamp":1790846003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293432600272X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S000293432600272X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.03.049","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of spironolactone in patients with heart failure with preserved ejection fraction following acute myocardial infarction: A multicenter retrospective cohort analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}